Search results for: 'Complex biologics'

This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredients mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthet...

Complexities in migration journeys form the key challenge for many end users in Australia, driven mainly by difficulties in migrating complex Big Data applications to the cloud. In addition, many enterprises now have heterogeneous environments consisting of legacy IT infrastructure and cloud-based applications, creating integration challenges in ma...

The Asia-Pacific cloud computing market is expected to grow at a CAGR of 28.4% during 2016–2022. Revenue grew 30.7% from 2015 to reach $11.34 billion in 2016. Cloud spending was dominated by Japan, Australia, and China in 2016. The key underlying theme across the markets is the increase in demand for managed cloud services. This arises due to Big D...

05 Feb 2021  |  Asia Pacific  |  Market Research

Increasingly Sophisticated Threat Landscape Drives the Uptake of Managed Security Services in APAC

Complex Business Environment and Insufficient Cybersecurity Make the Adoption of MSS a Top Technology Strategy

Infographics

×

Managed security service providers (MSSPs) offer managed security services (MSS) that help manage and monitor the security posture of their customers’ IT infrastructure. By using these services, client organizations are often able to reduce expenditure on either customer premises equipment (CPE) or in-house security specialists, and receive effecti...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

The Asia-Pacific (APAC) integrated facility management (IFM) market has experienced steady growth, primarily driven by developing economies. While mature markets have shown slower progress, the overall trend is positive. Strong regulatory support, particularly from the public sector, and a growing emphasis on energy efficiency have fueled IFM ad...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At AU...

The Asia-Pacific network security market grew healthily at a YoY growth of 17.5% in Q3 2018. The YoY growth of this quarter was much stronger as compared to the previous second quarter, which grew at 11.8% YoY. Businesses in the region are increasingly focused on the value of consolidation and integration provided by the security vendors to effecti...